Abstract
Introduction: The efficiency of the T1 sub-staging system on categorizing bladder cancer (BC) patients into subgroups with different clinical outcomes was unclear. We summarized relevant evidences, including recurrence-free survival (RFS), progression-free survival (PFS), and cancer-specific survival (CSS), to analyze the prognostic significance of T1 sub-stage. Methods: Systematic literature searches of MEDLINE, EMBASE, and the Cochrane Library were performed. We pooled data on recurrence, progression, and CSS from 35 studies. Results: The pooled hazard ratios (HRs) and 95% confidence intervals (CIs) indicated the difference in RFS between T1a sub-stage and T1b sub-stage (HR 1.28, 95% CI 1.14–1.43, p < 0.001). The significant difference was observed in PFS between the 2 arms (HR 2.18, 95% CI 1.95–2.44, p < 0.001). Worse CSS was found in T1b patients than in T1a patients (HR 1.36, 95% CI 1.21–1.54, p < 0.001). Conclusions: T1 sub-staging system based on the invasion depth into muscularis mucosae can be a significant prognostic factor for RFS, PFS, and CSS of patients with T1 BC. Urologists and pathologists are encouraged to work together to give a precise sub-stage classification of T1 BC, and T1 sub-staging system should be a routine part of any histopathological report when possible. Different treatment strategies need to be developed for both T1a BC and T1b BC.
References
1.
Andius
P
, Johansson
SL
, Holmäng
S
. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion
. Urology
. 2007
;70
(4
):758
–62
. 2.
Martin-Doyle
W
, Leow
JJ
, Orsola
A
, Chang
SL
, Bellmunt
J
. Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients
. J Clin Oncol
. 2015
;33
(6
):643
–50
. 3.
Sternberg
IA
, Keren Paz
GE
, Chen
LY
, Herr
HW
, Dalbagni
G
. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection
. BJU Int
. 2013
;112
(1
):54
–9
. 4.
Cookson
MS
, Chang
SS
, Wells
N
, Parekh
DJ
, Smith
JA
Jr. Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease
. J Urol
. 2003
;169
(1
):101
–4
. 5.
Parmar
MK
, Torri
V
, Stewart
L
. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
. Stat Med
. 1998
;17
(24
):2815
–34
. 6.
Higgins
JP
, Thompson
SG
, Deeks
JJ
, Altman
DG
. Measuring inconsistency in meta-analyses
. BMJ
. 2003
;327
(7414
):557
–60
. 7.
Hasui
Y
, Osada
Y
, Kitada
S
, Nishi
S
. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer
. Urology
. 1994
;43
(6
):782
–6
. 8.
Sözen
S
, Akbal
C
, Sökmensüer
C
, Ekici
S
, Özen
H
. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory)
. Urol Int
. 2002
;69
(3
):200
–6
. 9.
Lee
JY
, Joo
HJ
, Cho
DS
, Kim
SI
, Ahn
HS
, Kim
SJ
. Prognostic significance of substaging according to the depth of lamina propria invasion in primary T1 transitional cell carcinoma of the bladder
. Korean J Urol
. 2012
;53
(5
):317
–23
. 10.
Turan
T
, Efiloğlu
Ö
, Günaydin
B
, Özkanli
Ş
, Nikerel
E
, Atiş
G
, et al. Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
. Int Braz J Urol
. 2018
;44
(2
):267
–72
. 11.
Chang
WC
, Chang
YH
, Pan
CC
. Prognostic significance in substaging of T1 urinary bladder urothelial carcinoma on transurethral resection
. Am J Surg Pathol
. 2012
;36
(3
):454
–61
. 12.
Orsola
A
, Trias
I
, Raventós
CX
, Español
I
, Cecchini
L
, Búcar
S
, et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients
. Eur Urol
. 2005
;48
(2
):231
–8
. 13.
Soukup
V
, Babjuk
M
, Dusková
J
, Pešl
M
, Szakáczová
M
, Zámecník
L
, et al. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in T1 urothelial urinary bladder carcinoma?
Urol Int
. 2008
;80
(4
):413
–8
. 14.
Bertz
S
, Denzinger
S
, Otto
W
, Wieland
WF
, Stoehr
R
, Hofstaedter
F
, et al. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series
. Histopathology
. 2011
;59
(4
):722
–32
. 15.
Palou
J
, Sylvester
RJ
, Faba
OR
, Parada
R
, Peña
JA
, Algaba
F
, et al. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin
. Eur Urol
. 2012
;62
(1
):118
–25
. 16.
Nguyen-Huu
Y
, Delorme
G
, Lillaz
J
, Bedgedjian
I
, Le Ray-Ferrières
I
, Chabannes
E
, et al. [Muscularis mucosae invasion: prognostic factor for intravesical BCG immunotherapy failure for T1 bladder carcinoma]
. Prog Urol
. 2012
;22
(5
):284
–90
. 17.
Rouprêt
M
, Seisen
T
, Larre
S
, Comperat
E
, Mazerolles
C
, Fromont
G
, et al. 483 Prognostic interest to discriminate muscularis mucosae invasion (T1a vs. T1b) in non-muscle-invasive bladder carcinomas: results from a national multicentre study with a central pathology review
. Eur Urol Suppl
. 2013
;12
(1
):e483
–4
. 18.
De Marco
V
, Cerruto
MA
, D'Elia
C
, Brunelli
M
, Otte
O
, Minja
A
, et al. Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder
. Mol Clin Oncol
. 2014
;2
(4
):575
–80
. 19.
Soukup
V
, Dušková
J
, Pešl
M
, Čapoun
O
, Feherová
Z
, Zámečník
L
, et al. The prognostic value of T1 bladder cancer substaging: a single institution retrospective study
. Urol Int
. 2014
;92
(2
):150
–6
. 20.
Patschan
O
, Sjödahl
G
, Chebil
G
, Lövgren
K
, Lauss
M
, Gudjonsson
S
, et al. A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma
. Eur Urol
. 2015
;68
(5
):824
–32
. 21.
Breyer
J
, Bertz
S
, Müller
A
, Lausenmeyer
EM
, Mayr
R
, Gierth
M
, et al. 392 New pathological features predicting prognosis of early-invasive urothelial carcinoma: quantitative substaging and tumour invasion pattern should assist WHO 1973 grading classification in predicting cancer-specific survival of stage pT1 bladder cancer
. Eur Urol Suppl
. 2016
;15
(3
):e392
. 22.
Patriarca
C
, Hurle
R
, Moschini
M
, Freschi
M
, Colombo
P
, Colecchia
M
, et al. Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
. Diagn Pathol
. 2016
;11
:6
. 23.
Colombo
R
, Hurle
R
, Moschini
M
, Freschi
M
, Colombo
P
, Colecchia
M
, et al. Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 high-grade bladder cancer
. Eur Urol Focus
. 2018
;4
(1
):87
–93
. 24.
Jeandin
E
, Dupont
A
, Tille
J-C
, Hauser
J
, Tran
S-N
, Regusci
S
, et al. Pathological substaging of pT1 urothelial bladder carcinoma is associated with tumor progression
. Eur Urol Suppl
. 2018
;17
(2
):e1069
. 25.
Smits
G
, Schaafsma
E
, Kiemeney
L
, Caris
C
, Debruyne
F
, Witjes
JA
. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression
. Urology
. 1998
;52
(6
):1009
–4
. 26.
Bernardini
S
, Billerey
C
, Martin
M
, Adessi
GL
, Wallerand
H
, Bittard
H
. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma
. J Urol
. 2001
;165
(1
):42
–6
. 27.
Denzinger
S
, Otto
W
, Fritsche
HM
, Roessler
W
, Wieland
WF
, Hartmann
A
, et al. Bladder sparing approach for initial T1G3 bladder cancer: do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients
. Int J Urol
. 2007
;14
(11
):995
–9
. 28.
Queipo-Zaragoza
JA
, Ruiz-Cerda
JL
, Vera-Donoso
CD
, Vera-Sempere
F
, Budia-Alba
A
, Jimenez-Cruz
JF
. Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression
. Scand J Urol Nephrol
. 2007
;41
(4
):283
–9
. 29.
Orsola
A
, Raventós
C
, Allué
M
, Lozano
F
, Delgado
G
, Bastarós
JM
, et al. 1752 optimizing therapeutic strategies in initial high grade T1 bladder cancer: post-bcg second tur according to lamina propria invasion microstaging (T1 A/b)
. J Urol
. 2011
;185
(4S
):e703
. 30.
van Rhijn
BW
, Liu
L
, Vis
AN
, Bostrom
PJ
, Zuiverloon
TC
, Fleshner
NE
, et al. Prognostic value of molecular markers, sub-stage and European organisation for the research and treatment of cancer risk scores in primary T1 bladder cancer
. BJU Int
. 2012
;110
(8
):1169
–76
. 31.
Holmäng
S
, Hedelin
H
, Anderström
C
, Holmberg
E
, Johansson
SL
. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study
. J Urol
. 1997
;157
(3
):800
–3
. 32.
Cheng
L
, Neumann
RM
, Weaver
AL
, Spotts
BE
, Bostwick
DG
. Predicting cancer progression in patients with stage T1 bladder carcinoma
. J Clin Oncol
. 1999
;17
(10
):3182
–7
. 33.
Kondylis
FI
, Demirci
S
, Ladaga
L
, Kolm
P
, Schellhammer
PF
. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma
. J Urol
. 2000
;163
(4
):1120
–3
. 34.
Shariat
SF
, Weizer
AZ
, Green
A
, Laucirica
R
, Frolov
A
, Wheeler
TM
, et al. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder
. Urology
. 2000
;56
(5
):735
–40
. 35.
Mhawech-Fauceglia
P
, Fischer
G
, Alvarez
V
Jr, Ahmed
A
, Herrmann
FR
. Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis
. BJU Int
. 2007
;100
(5
):1182
–7
. 36.
Faivre d’Arcier
B
, Celhay
O
, Safsaf
A
, Zairi
A
, Pfister
C
, Soulié
M
, et al. [T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French urological association (CCAFU)]
. Prog Urol
. 2010
;20
(6
):440
–9
. 37.
Van Rhijn
BW
, Van Der Kwast
TH
, Alkhateeb
SS
, Fleshner
NE
, Van Leenders
GJ
, Bostrom
PJ
, et al. A new and highly prognostic system to discern T1 bladder cancer substage
. Eur Urol
. 2012
;61
(2
):378
–84
. 38.
Brimo
F
, Wu
C
, Zeizafoun
N
, Tanguay
S
, Aprikian
A
, Mansure
JJ
, et al. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion
. Hum Pathol
. 2013
;44
(1
):95
–102
. 39.
Orsola
A
, Werner
L
, De Torres
I
, Martin-Doyle
W
, Raventos
CX
, Lozano
F
, et al. Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients
. Br J Cancer
. 2015
;112
(3
):468
–74
. 40.
Fransen van de Putte
EE
, Otto
W
, Hartmann
A
, Bertz
S
, Mayr
R
, Bründl
J
, et al. Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer
. Urol Oncol
. 2018
;36
(8
):361.e7
–e13
. 41.
Ro
JY
, Ayala
AG
, el-Naggar
A
. Muscularis mucosa of urinary bladder. Importance for staging and treatment
. Am J Surg Pathol
. 1987
;11
(9
):668
–73
.42.
Angulo
JC
, Lopez
JI
, Grignon
DJ
, Sanchez-Chapado
M
. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer
. Urology
. 1995
;45
(1
):47
–53
. 43.
Cottrell
L
, Nairn
ER
, Hair
M
. Consistency of microstaging pT1 bladder transitional cell carcinoma
. J Clin Pathol
. 2007
;60
(6
):735
–6
. 44.
Segal
R
, Yafi
FA
, Brimo
F
, Tanguay
S
, Aprikian
A
, Kassouf
W
. Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
BJU Int
. 2012
;109
(7
):1026
–30
. 45.
Lopez-Beltran
A
, Cheng
L
. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance
. Pathology
. 2003
;35
(6
):484
–91
. 46.
Dixon
JS
, Gosling
JA
. Histology and fine structure of the muscularis mucosae of the human urinary bladder
. J Anat
. 1983
;136
(Pt 2
):265
–71
.47.
Kramer
MW
, Rassweiler
JJ
, Klein
J
, Martov
A
, Baykov
N
, Lusuardi
L
, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor
. World J Urol
. 2015
;33
(12
):1937
–43
. 48.
Zhang
XR
, Feng
C
, Zhu
WD
, Si
JM
, Gu
BJ
, Guo
H
, et al. Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? a randomized prospective study
. Photomed Laser Surg
. 2015
;33
(10
):517
–23
. 49.
Deeks
JJ
, Macaskill
P
, Irwig
L
. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
. J Clin Epidemiol
. 2005
;58
(9
):882
–93
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
